Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
5.75
+0.06 (1.05%)
Dec 20, 2024, 4:00 PM EST - Market closed
Voyager Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for VYGR stock have an average target of 16.44, with a low estimate of 7.00 and a high estimate of 30. The average target predicts an increase of 185.91% from the current stock price of 5.75.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VYGR stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 5 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +108.70% | Dec 2, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +143.48% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +421.74% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +421.74% | Oct 24, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $15 | Buy | Initiates | $15 | +160.87% | Oct 16, 2024 |
Financial Forecast
Revenue This Year
90.95M
from 250.01M
Decreased by -63.62%
Revenue Next Year
70.31M
from 90.95M
Decreased by -22.70%
EPS This Year
-0.95
from 2.97
EPS Next Year
-1.66
from -0.95
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 103.4M | 151.2M | 154.3M | |||
| Avg | 90.9M | 70.3M | 80.8M | |||
| Low | 77.1M | 3.9M | 19.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -58.6% | 66.3% | 119.5% | |||
| Avg | -63.6% | -22.7% | 15.0% | |||
| Low | -69.2% | -95.7% | -72.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.69 | -0.66 | -0.51 | |||
| Avg | -0.95 | -1.66 | -1.27 | |||
| Low | -1.03 | -3.02 | -1.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.